Genetic Factors in Antidepressant Side Effects Unveiled by Biobank Data
A groundbreaking study using biobank data reveals how genetic variations influence the severity of side effects from antidepressants, paving the way for personalized mental health treatments.
Recent research conducted by scientists at the University of Tartu's Institute of Genomics has shed light on why some individuals experience more pronounced side effects when using antidepressants. By analyzing data from over 13,000 gene donors stored in the Estonian Biobank, researchers examined 25 common side effects across 16 popular antidepressants, including symptoms like nausea, weight fluctuations, sleep disturbances, headaches, and heart palpitations.
The study focused significantly on the CYP2C19 gene, which plays a crucial role in how the body metabolizes certain medications. Variations in this gene, especially the presence of a deletion mutation found in over 3% of Estonians—a genetic trait not previously documented in other populations—were linked to an increased likelihood of side effects. Slow metabolizers, who process drugs more slowly due to their genetic makeup, were nearly 50% more likely to experience adverse effects compared to those with typical metabolic rates, whereas ultra-rapid metabolizers exhibited a lower risk.
These findings emphasize the importance of personalized medicine, suggesting that genetic testing could guide dosage adjustments or alternative therapies to minimize side effects. For example, patients can check their CYP2C19 activity through the Minu Geenivaramu portal. Incorporating genetic variants like the CYP2C19 deletion into pharmacogenetic testing can enhance treatment safety, especially in Estonia.
Furthermore, the research linked genetic predispositions for psychiatric conditions such as schizophrenia and depression, as well as higher BMI, with increased side effect profiles, including weight gain and headaches. Using data mining and natural language processing on clinical records and questionnaires, scientists demonstrated the significant influence of genetics on individual responses to antidepressants.
Overall, this innovative study highlights the potential of using genetic information to tailor antidepressant therapy, leading to more effective and safer mental health treatments while reducing the risk of therapy discontinuation due to adverse effects. The results underscore the importance of integrating pharmacogenetics into clinical practice to optimize patient outcomes.
Source: https://medicalxpress.com/news/2025-07-biobank-individuals-side-effects-antidepressants.html
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
The Importance of Regular Depression Screenings for High School Students
Rising rates of depression and suicidal thoughts among high school students highlight the need for routine mental health screenings to identify at-risk youth early and provide essential support.
Elevated Emotional Challenges for Neurodivergent Adolescents at School
Neurodivergent adolescents face twice the emotional burden from negative school experiences, increasing their risk of depression and anxiety. New research emphasizes the importance of supportive, neurodiversity-informed school environments.
College Drinking May Harm Academic Performance and Mental Well-Being of Peers
A new study shows that college students exposed to peers' alcohol-related harm face lower academic performance and increased mental health issues, emphasizing the need for better campus prevention policies.